Quantcast
The MFWire
Manage Email Alerts | Sponsorships | About MFWire | Who We Are

Subscribe to MFWire.com's News Alerts [click]

Rating:Swank Discusses the Future of Rydex Not Rated 2.2 Email Routing List Email & Route  Print Print
Friday, January 18, 2008

Swank Discusses the Future of Rydex

Reported by Erin Kello

Now that the Security Benefit-Rydex deal is complete, the MFWire had a conversation with Tom Swank, president and chief operating officer of Topeka, Kansas-based Security Benefit, to get a sense of what the future holds for the combined organization.

"Our companies have complementary skill sets," Swank told the MFWire, "we will focus on maximizing the benefits of both."

Rydex will operate as an independent subsidiary of Security Benefit and the Rockville, Maryland-based fund firm's current management structure will stay intact, Swank said.

Security Benefit plans to leverage one of Rydex's strongest products, ETFs, in its own 401(k) and 403(b) plan offerings.

Swank said he also foresees being able to bring new Rydex products to market within six to nine months. Swank said that Security Benefit plans on retaining the Rydex name on products due to the strong brand it has developed.

Asked whether Security Benefit intends to make more acquisitions, Swank said the company "doesn't currently have anything else in the hopper."  

Stay ahead of the news ... Sign up for our email alerts now
CLICK HERE

2.2
 Do You Recommend This Story?



GO TO: MFWire
Return to Top
 News Archives
2024: Q2Q1
2023: Q4Q3Q2Q1
2022: Q4Q3Q2Q1
2021: Q4Q3Q2Q1
2020: Q4Q3Q2Q1
2019: Q4Q3Q2Q1
2018: Q4Q3Q2Q1
2017: Q4Q3Q2Q1
2016: Q4Q3Q2Q1
2015: Q4Q3Q2Q1
2014: Q4Q3Q2Q1
2013: Q4Q3Q2Q1
2012: Q4Q3Q2Q1
2011: Q4Q3Q2Q1
2010: Q4Q3Q2Q1
2009: Q4Q3Q2Q1
2008: Q4Q3Q2Q1
2007: Q4Q3Q2Q1
2006: Q4Q3Q2Q1
2005: Q4Q3Q2Q1
2004: Q4Q3Q2Q1
2003: Q4Q3Q2Q1
2002: Q4Q3Q2Q1
 Subscribe via RSS:
Raw XML
Add to My Yahoo!
follow us in feedly




©All rights reserved to InvestmentWires, Inc. 1997-2024
14 Wall Street | 20th Floor | New York, NY 10005 | P: 212-331-8968 | F: 212-331-8998
Privacy Policy :: Terms of Use